TGFβ1-IN-5
TGFβ1-IN-5 is a TGF-β1 inhibitor with blood-brain barrier permeability. TGFβ1-IN-5 reduces extracellular TGF-β1 levels in glioblastoma cells. TGFβ1-IN-5 exerts antiproliferative, antimigratory and clonogenic inhibitory effects in glioblastoma cells while maintaining the viability of non-cancerous cells. TGFβ1-IN-5 can be used for the research of glioblastoma.
For research use only. We do not sell to patients.
- Formula: C31H25BrN2O3
- Molecular Weight:553.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
TGFβ1-IN-5 (Compound 3e) (0-100 μM; 24 h) exhibits moderately potent selective antiproliferative activity against U87 cells (IC50 = 41.09 μM), while showing no significant inhibitory effect on non-cancerous cells BEAS-2B and HUVEC[1].
TGFβ1-IN-5 (41 μM; 24 h) reduces extracellular TGF-β1 levels in U87 glioblastoma cells[1].
TGFβ1-IN-5 (20-80 μM; 24 h) reduces the number of U87 glioblastoma cells in a concentration-dependent manner, but exerts no significant effect on the number of non-cancerous HUVEC cells[1].
TGFβ1-IN-5 (41 μM; 72 h) significantly inhibits the migration of U87 glioblastoma cells in a time-dependent manner[1].
TGFβ1-IN-5 (41 μM; 5 days) inhibits the long-term clonogenic potential of U87 glioblastoma cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:U87 cells, BEAS-2B cells, HUVEC cells
-
Concentration:0,
1.5, 3.1, 6.2, 12.5, 25, 50, and 100 μM -
Incubation Time:24 h
-
Result:Showed moderate anti-proliferative activity in U87 cells with an IC50 of 41.09 μM.
Maintained high viability in non-cancerous cells, with IC50 values ≥96.60 μM in BEAS-2B and HUVEC cells.
Increased cell number in HUVEC and BEAS-2B cells at concentrations ≤3.125 μM.
Increased cell number in U87 cells at concentrations ≤12.5 μM.
-
Cell Line:human glioblastoma U87 cells
-
Concentration:41 μM
-
Incubation Time:24 h
-
Result:Caused a 5.5% decrease in extracellular TGF-β1 levels (88.90 pg/mL) compared to untreated control cells (94.11 pg/mL).
-
Cell Line:human glioblastoma U87 cells
-
Concentration:41 μM
-
Incubation Time:72 h
-
Result:Significantly delayed wound closure compared to control cells at all time points.
Chemical Information
-
Molecular Weight 553.45
-
Formula C31H25BrN2O3
-
SMILES
O=C(C1=CC=CC=C1)/C=C/C2=CC=C(N3C=[N+](CC4=CC=C(C(OC)=O)C=C4)C5=CC=CC=C35)C=C2.[Br-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)